4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-056427
President and CEO sold 42,000 shares at an average $20.06 ($842,520)
- President and CEO acquired 42,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2022-11-08 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-11-08 | Sale | −14,000 | $20.18 | $282,520 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-11-10 | Option exercise | +18,175 | $4.12 | $74,881 | 272,729 | D |
| Patel Sanjiv President and CEO | 2022-11-10 | Sale | −18,175 | $20.00 | $363,500 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-11-10 | Option exercise | +9,825 | $5.04 | $49,518 | 264,379 | D |
| Patel Sanjiv President and CEO | 2022-11-10 | Sale | −9,825 | $20.00 | $196,500 | 254,554 | D |
| Derivatives | |||||||
| Patel Sanjiv President and CEO | 2022-11-08 | Option exercise · Stock Option (Right to Buy) | −14,000 | 18,175 | D | ||
| Patel Sanjiv President and CEO | 2022-11-10 | Option exercise · Stock Option (Right to Buy) | −18,175 | 0 | D | ||
| Patel Sanjiv President and CEO | 2022-11-10 | Option exercise · Stock Option (Right to Buy) | −9,825 | 694,779 | D | ||
| Open-market sales · 42,000 sh · avg $20.06 · $842,520 | |||||||
Loading xslF345X03/doc4.xml…